In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing
Abstract Background In November 2021, variant B. 1.1. 529 of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) was identified by the World Health Organization …
syndrome coronavirus 2 (SARS-CoV-2) was identified by the World Health Organization …
[HTML][HTML] A clustering and graph deep learning-based framework for COVID-19 drug repurposing
Drug repurposing (or repositioning) is the process of finding new therapeutic uses for drugs
already approved by drug regulatory authorities (eg, the Food and Drug Administration …
already approved by drug regulatory authorities (eg, the Food and Drug Administration …